Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer Journal Article


Authors: Isbarn, H.; Karakiewicz, P. I.; Shariat, S. F.; Capitanio, U.; Palapattu, G. S.; Sagalowsky, A. I.; Lotan, Y.; Schoenberg, M. P.; Amiel, G. E.; Lerner, S. P.; Sonpavde, G.
Article Title: Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer
Abstract: Purpose: We hypothesized that in patients with T2N0 stage disease at transurethral bladder tumor resection a lower residual cancer stage (P1N0 or less) at radical cystectomy may correlate with improved outcomes relative to those with residual P2N0 disease. Materials and Methods: We analyzed 208 patients with T2N0 stage disease at transurethral bladder tumor resection whose tumors were organ confined at radical cystectomy (P2 or lower; pN0). None received perioperative chemotherapy. Kaplan-Meier as well as univariable and multivariable Cox regression models addressed the effect of residual pT stage at radical cystectomy on recurrence and cancer specific mortality rates. Covariates consisted of age, gender, grade, lymphovascular invasion, carcinoma in situ, number of lymph nodes removed and year of surgery. Results: Residual pT stage at radical cystectomy was PO in 24 (11.5%) patients, Pa in 9 (4.3%), PCIS in 22 (10.6%), P1 in 35 (16.8%) and P2 in 118 (56.7%). Median followup of censored patients was 55.7 months for recurrence and 52.1 months for cancer specific mortality analyses. The 5-year recurrence-free survival rates of patients with PO/Pa/PCIS, P1 and P2 stage disease were 100%, 85% and 75%, respectively. The 5-year cancer specific survival rates for the same cohorts were 100%, 93% and 81%, respectively. On multivariable analysis the effect of residual stage PI or lower at radical cystectomy achieved independent predictor status for recurrence (adjusted HR 0.20, p = 0.002) and cancer specific mortality (adjusted HR 0.24, p = 0.02). Conclusions: Down staging from initial T2N0 bladder cancer at transurethral bladder tumor resection to lower stage at radical cystectomy significantly reduces recurrence and cancer specific mortality. Further validation of this finding is warranted.
Keywords: survival; neoplasm staging; recurrence; urinary bladder neoplasms; risk; cystectomy; carcinoma; transurethral resection; invasion; nomogram; transitional cell; transitional-cell carcinoma; disease; lymphovascular; specimens
Journal Title: Journal of Urology
Volume: 182
Issue: 2
ISSN: 0022-5347
Publisher: Elsevier Science, Inc.  
Date Published: 2009-01-01
Start Page: 459
End Page: 465
Language: English
ACCESSION: ISI:000267850300013
DOI: 10.1016/j.juro.2009.04.017
PROVIDER: wos
PUBMED: 19524971
Notes: --- - Article - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Shahrokh Shariat
    68 Shariat